Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1950 2
1951 1
1953 1
1954 1
1955 1
1957 2
1958 2
1959 2
1961 1
1962 1
1963 2
1964 2
1965 1
1966 3
1967 1
1968 2
1969 5
1970 3
1971 1
1972 5
1973 5
1974 4
1975 7
1976 4
1977 3
1978 7
1979 12
1980 8
1981 13
1982 13
1983 8
1984 14
1985 15
1986 23
1987 25
1988 33
1989 27
1990 23
1991 21
1992 31
1993 30
1994 40
1995 38
1996 40
1997 33
1998 46
1999 37
2000 46
2001 40
2002 36
2003 40
2004 31
2005 46
2006 41
2007 58
2008 73
2009 66
2010 67
2011 80
2012 66
2013 66
2014 72
2015 75
2016 56
2017 59
2018 47
2019 50
2020 62
2021 60
2022 47
2023 39
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

1,760 results

Results by year

Filters applied: . Clear all
Page 1
Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers.
Skorupan N, Peer CJ, Zhang X, Choo-Wosoba H, Ahmad MI, Lee MJ, Rastogi S, Sato N, Yu Y, Pegna GJ, Steinberg SM, Kalsi SS, Cao L, Figg WD, Trepel JB, Pastan I, FitzGerald D, Alewine C. Skorupan N, et al. Among authors: steinberg sm. Front Oncol. 2024 Apr 19;14:1386190. doi: 10.3389/fonc.2024.1386190. eCollection 2024. Front Oncol. 2024. PMID: 38706610 Free PMC article.
High-dose Alemtuzumab-Cyclosporine vs Tacrolimus-Methotrexate-Sirolimus for Chronic Graft-versus-Host Disease Prevention.
Holtzman NG, Curtis LM, Salit RB, Shaffer BC, Pirsl F, Ostojic A, Steinberg SM, Schulz E, Wilder JS, Hughes TE, Rose J, Memon S, Korngold R, Gea-Banacloche J, Fowler DH, Hakim FT, Gress RE, Bishop MR, Pavletic SZ. Holtzman NG, et al. Among authors: steinberg sm. Blood Adv. 2024 Apr 26:bloodadvances.2023010973. doi: 10.1182/bloodadvances.2023010973. Online ahead of print. Blood Adv. 2024. PMID: 38669315
Pulmonary Metastasectomy for Adrenocortical Carcinoma-Not If, but When.
Carr SR, Villa Hernandez F, Varghese DG, Choo-Wosoba H, Steinberg SM, Teke ME, Del Rivero J, Schrump DS, Hoang CD. Carr SR, et al. Among authors: steinberg sm. Cancers (Basel). 2024 Feb 7;16(4):702. doi: 10.3390/cancers16040702. Cancers (Basel). 2024. PMID: 38398093 Free PMC article.
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma.
Monge C, Xie C, Myojin Y, Coffman-D'Annibale KL, Hrones D, Brar G, Wang S, Budhu A, Figg WD, Cam M, Finney R, Levy EB, Kleiner DE, Steinberg SM, Wang XW, Redd B, Wood BJ, Greten TF. Monge C, et al. Among authors: steinberg sm. Cancer Med. 2024 Feb;13(3):e6912. doi: 10.1002/cam4.6912. Epub 2024 Jan 11. Cancer Med. 2024. PMID: 38205877 Free PMC article.
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial.
Coffman-D'Annibale K, Myojin Y, Monge C, Xie C, Hrones DM, Wood BJ, Levy EB, Kleiner D, Figg WD, Steinberg SM, Redd B, Greten TF. Coffman-D'Annibale K, et al. Among authors: steinberg sm. J Immunother Cancer. 2024 Jan 6;12(1):e008079. doi: 10.1136/jitc-2023-008079. J Immunother Cancer. 2024. PMID: 38184304 Free PMC article. Clinical Trial.
1,760 results